Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening and identification of phytochemical drug molecules against mutant BRCA1 receptor of breast cancer using computational approaches.

Molecular and cellular biochemistry - 1 Mar 2022

Singh Jitender, Sangwan Namrata, Chauhan Arushi, Sarma Phulen, Prakash Ajay, Medhi Bikash, Avti Pramod K

Abstract excerpt

The American Cancer Society claims that breast cancer is the second most significant cause of cancer-related death, with over one million women diagnosed each year. Breast cancer linked to the BRCA1 gene has a significant risk of mortality and recurrence and is susceptible to alteration or over-expression, which can lead to hereditary breast cancer. Given the shortage of effective and possibly curative treatments...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Phytogenic
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Molecular Docking Simulation

Share to Mutation

Source

Identifiers

PMID: 35067782
DOI: 10.1007/s11010-021-04338-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening and identification of phytochemical drug molecules against mutant BRCA1 receptor of breast cancer using computational approaches.PMID 35067782Read ↗

Potential Phytochemicals for Prevention of Familial Breast Cancer with BRCA Mutations.Semantic proximity Read ↗

In silico screening and identifying phytoconstituents of Withania somnifera as potent inhibitors of BRCA1 mutants: A therapeutic against breast cancer.Semantic proximity Read ↗

Exploring Moringa oleifera Phytochemicals as Potential Inhibitors for HIF- 1α/VEGF/GLUT1 pathway in Breast Cancer Using Molecular Docking, MD Simulations, and DFT AnalysisSemantic proximity Read ↗

Natural Compounds or Their Derivatives against Breast Cancer: A Computational Study.Semantic proximity Read ↗

Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic ViewpointSemantic proximity Read ↗

Selected Ideal Natural Ligand Against TNBC by Inhibiting CDC20, Using Bioinformatics and Molecular BiologySemantic proximity Read ↗

Molecular docking and MD simulation approach to identify potential phytochemical lead molecule against triple negative breast cancerSemantic proximity Read ↗

Integrating machine learning driven virtual screening and molecular dynamics simulations to identify potential inhibitors targeting PARP1 against prostate cancerSemantic proximity Read ↗

In-silico analysis reveals Quinic acid as a multitargeted inhibitor against Cervical CancerSemantic proximity Read ↗

A structural bioinformatics approach to explore the interactions of P53 and BRCA1 gene products on ovarian and breast cancer.Semantic proximity Read ↗

Network Pharmacology and In Silico Approach to Study the Mechanism of Quercetin against Breast CancerSemantic proximity Read ↗

Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics StudiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.